Research

Researchers at Trinity College Dublin are inviting people living with Multiple Sclerosis (MS) to take part in a study exploring how MS affects walking and mobility in everyday life.

Researchers, clinicians, healthcare professionals, people living with MS and members of the wider MS community are invited to attend two free MS research events taking place at Queen's University Belfast on Friday, 26 June 2026.

The University of Galway is now recruiting people living with MS in Galway and Dublin to take part in the COB-MS programme.

MS Ireland is inviting contributions from researchers, clinicians, policymakers, patient advocates, and others working in digital health and artificial intelligence to help inform an upcoming webinar in the MS Ireland EU Presidency Webinar Series.

Researchers at Dublin City University (DCU) are inviting people living with MS and other mobility impairments to take part in a new study exploring experiences of cancer care in Ireland.

Applications are now open for the 2026 Rachel Horne Prize for Women's Research in MS, an international award recognising outstanding women leading research in multiple sclerosis (MS).

Researchers at University College Cork are inviting people to take part in a study exploring patients’ experiences of medication-related care in hospital outpatient clinics. The study aims to understand how discussions about medicines take place during outpatient visits and how these services can be improved to better support patients.

The All Ireland Multiple Sclerosis Research Network (AIMS-RN) has announced a call for abstracts for its upcoming Research Symposium, taking place on 26 June 2026 at Queen’s University Belfast.

Postmenopausal women with MS quality of life study conducted by Dr Orna O’Toole. This research looks at how Multiple Sclerosis affects quality of life after menopause and whether hormone therapy can make a difference.

The AIMS-RN Symposium, held at Maynooth University on 6 June 2025, brought together researchers from across the island of Ireland to showcase high-quality multiple sclerosis (MS) research.